Clinical Trial Update: Role of Serum ADAM 17 (A Disintegrin And Metalloprotease 17) and Caspase 3 in Patients With Chronic Kidney Disease

View source ↗

Summary

This clinical trial investigates the roles of serum ADAM17 and caspase-3 as biomarkers in chronic kidney disease. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Assiut University | Conditions: Chronic Kidney Diseases | Status: NOT_YET_RECRUITING